Biocryst Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 22.27 M | $173.73 M | 2.21% | 10.60% |
| BLACKROCK, INC. | 02/12/2026 | 21.14 M | $164.87 M | -0.51% | 10.06% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 15.83 M | $123.45 M | 100.00% | 7.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 14.34 M | $111.86 M | 17.85% | 6.82% |
| STATE STREET CORP | 02/13/2026 | 11.07 M | $86.37 M | 12.91% | 5.27% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 9.37 M | $73.06 M | -0.25% | 4.46% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 7.40 M | $57.79 M | 7,807.21% | 3.52% |
| UBS GROUP AG | 01/29/2026 | 5.26 M | $41.06 M | -11.79% | 2.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.05 M | $39.43 M | 0.03% | 2.40% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 4.52 M | $35.22 M | 2.17% | 2.15% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 4.09 M | $31.90 M | -3.57% | 1.95% |
| 04/01/2026 | 3.85 M | $30.00 M | 100.00% | 1.83% | |
| NUVEEN, LLC | 02/12/2026 | 3.61 M | $28.18 M | -0.15% | 1.72% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 3.21 M | $25.06 M | 18.47% | 1.53% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 3.16 M | $24.67 M | 100.00% | 1.50% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 3.16 M | $24.66 M | 43.82% | 1.50% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 2.99 M | $23.34 M | 117.88% | 1.42% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 2.82 M | $22.02 M | 100.00% | 1.34% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2.54 M | $19.83 M | 21.41% | 1.21% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 2.47 M | $19.25 M | -6.27% | 1.17% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 2.25 M | $17.55 M | 100.00% | 1.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 2.16 M | $16.88 M | -10.21% | 1.03% |
| 02/17/2026 | 2.15 M | $16.77 M | 100.00% | 1.02% | |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.13 M | $16.60 M | -0.55% | 1.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 2.00 M | $15.64 M | 0.53% | 0.95% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 1.90 M | $14.85 M | 1.26% | 0.91% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.86 M | $14.48 M | -1.86% | 0.88% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 1.82 M | $14.23 M | 0.08% | 0.87% |
| MORGAN STANLEY | 02/13/2026 | 1.75 M | $13.62 M | -66.45% | 0.83% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 1.74 M | $13.59 M | 93.21% | 0.83% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 1.66 M | $12.94 M | 49.66% | 0.79% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.54 M | $11.98 M | -19.30% | 0.73% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.36 M | $10.58 M | 100.00% | 0.65% |
| INVESCO LTD. | 02/19/2026 | 1.35 M | $10.57 M | 40.79% | 0.64% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.30 M | $10.13 M | -4.48% | 0.62% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.25 M | $9.73 M | -27.02% | 0.59% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.23 M | $9.59 M | 100.00% | 0.58% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.21 M | $9.47 M | 409.51% | 0.58% |
| JUPITER ASSET MANAGEMENT LTD | 02/10/2026 | 1.20 M | $9.34 M | -41.75% | 0.57% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 1.03 M | $8.05 M | 178.43% | 0.49% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 1.02 M | $7.94 M | 100.00% | 0.48% |
| ABRDN PLC | 01/16/2026 | 913.59 K | $7.13 M | 100.00% | 0.43% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 910.93 K | $7.11 M | -1.50% | 0.43% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 900.06 K | $7.02 M | -11.12% | 0.43% |
| JPMORGAN CHASE & CO | 02/11/2026 | 843.37 K | $6.58 M | -25.52% | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 837.89 K | $6.54 M | 100.00% | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 800.00 K | $6.24 M | 0.00% | 0.38% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 778.52 K | $6.07 M | 100.00% | 0.37% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 740.51 K | $5.71 M | -38.10% | 0.35% |
| BARCLAYS PLC | 02/13/2026 | 726.37 K | $5.67 M | -7.14% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biocryst Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 407 institutional investors and hedge funds held shares of Biocryst Pharmaceuticals Inc.. The most heavily invested institutionals were:
abrdn plc: 5.04 M
UBS Group AG: 4.94 M
Nuveen, LLC: 3.82 M
RFG Advisory, LLC: 2.87 M
Fisher Asset Management, LLC: 2.73 M
DIMENSIONAL FUND ADVISORS LP: 2.69 M
101.12% of Biocryst Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 265.28 M shares in the last 24 months. This purchase volume represents approximately $2.29 B in transactions.